Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
CRNX on Nasdaq
Richard Scott Struthers - trading volume in the past year for Crinetics Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
571K |
$1.09M |
$1.91 |
Apr 2, 2025 |
By Family Trust 1 |
|
|
| Common Stock |
410K |
$784K |
$1.91 |
Apr 2, 2025 |
Direct |
|
|
| Common Stock |
110K |
$210K |
$1.91 |
Apr 2, 2025 |
By Family Trust 2 |
|
|
| Common Stock |
110K |
$210K |
$1.91 |
Apr 2, 2025 |
By Family Trust 3 |
|
|
| Common Stock |
100K |
$191K |
$1.91 |
Apr 2, 2025 |
By Family Trust 4 |
|
|
| Common Stock |
1K |
$1.91K |
$1.91 |
Apr 2, 2025 |
By Spouse |
|
|
| Stock Option (Right to Buy) |
0 |
|
|
Apr 2, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.